# Rebecca D. Ganetzky, M.D. – FDA Inspection, Apr 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/rebecca-d-ganetzky-md/bd6ddc1d-c4e6-48d6-8836-9f10fb55cbf0
Source feed: FDA_Inspections

> FDA inspection 1269018 of Rebecca D. Ganetzky, M.D., April 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269018
- Company Name: Rebecca D. Ganetzky, M.D.
- Inspection Date: 2025-04-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.keypedia.com/companies/rebecca-d-ganetzky-md/ac3c36a0-fa8d-411b-b969-e9c4cb0c6d5b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c